Permian Resources Corporation heads into late May with price weakness accelerating, options traders turning more defensive, and a cluster of insider sales from the spring still fresh in the register.
The stock fell 7.5% on the week to close at $19.63, extending a 4.2% slide over the past month. The selloff is sector-wide — closest peers OVV, CHRD, MTDR, and DVN all dropped between 6% and 12% over the same five days — but PR's drawdown sits at the heavier end of the group. MTDR led the peer declines at -11.6%, while FANG held up best at -5.1%, highlighting some divergence within the E&P space even as crude headwinds hit the whole cohort.
Options positioning has grown noticeably more cautious. The put/call ratio climbed to 0.31 by Tuesday, well above its 20-day average of 0.24 and running at a z-score of 1.4 — the highest defensive reading since the 0.51 peak recorded over the past year. To put that in context: the PCR hovered near 0.19-0.20 throughout late April. Since mid-May it has stepped up steadily, mirroring the stock's price deterioration and suggesting hedging demand is building, not spiking — a methodical repositioning rather than a one-day panic. The next earnings date is August 4, and options traders appear to be pricing in downside risk early.
Short positioning itself tells a less alarming story. At 2.47% of the free float, short interest has eased roughly 8% over the past month — not a meaningful short base, and the borrow market is far from stressed. Availability is extraordinarily loose at over 7,400%, meaning shares to borrow dwarf the current short position by a factor of more than 74. Cost to borrow runs near 0.40%, down sharply from a brief spike above 0.60% on May 19. There is no mechanical squeeze setup here: the lending market is reflecting a commodity-name that anyone can short cheaply and easily if they choose to.
The Street remains tilted bullish, even as targets inch up with little urgency. Mizuho raised its target to $27 this week while maintaining Outperform — a constructive read given the price is sitting near $19.63, implying roughly 38% upside to the mean analyst target of $25.74. Earlier in April, Wells Fargo, Scotiabank, and Truist all lifted targets, predominantly from the low-$20s into the mid-$20s, without changing ratings. The only dissent came from Roth Capital, which stepped back to Neutral in early April, flagging valuation risk. Valuation multiples have compressed alongside the price: the EV/EBITDA multiple has contracted roughly 0.27x over the past 30 days to 4.5x, and the P/E has shed nearly a full turn to just under 9.8x. The bull case centres on 99% WTI oil realisation through new midstream contracts and 3-4% volume growth; the bear case points to declining well productivity and the risk that oil weakens below the $70/bbl threshold needed to sustain free cash flow.
Insider activity adds a cautionary note. The CFO sold $1.28 million worth of shares on May 21 at $20.44 — a price level the stock has since broken below. Earlier in the spring, Co-CEO Will Hickey sold over $16.5 million in early March, director William Quinn sold $10 million in mid-March, and Pearl Energy Investments disposed of $15.3 million. Net insider selling over the 90-day window totalled roughly $60 million across more than 3.1 million net shares. None of these trades carries unusually high significance scores, and selling by energy-company insiders around multi-year price levels is common. But the scale and breadth of the spring selling cluster — spread across the CFO, Co-CEO, General Counsel, and major director-level shareholders — is worth noting as the stock retreats toward the prices at which those sales were executed.
Earnings on August 4 will test whether improving midstream economics and volume guidance can offset the commodity price softness now being priced into both the shares and the options market.
See the live data behind this article on ORTEX.
Open PR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.